A · Agilent Technologies, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.80B | - | $1.74B | $1.67B | $1.68B | - | $1.58B | $1.57B | $1.66B | - |
| Cost of Revenue | $852.00M | - | $850.00M | $802.00M | $782.00M | - | $723.00M | $717.00M | $750.00M | - |
| Gross Profit | $946.00M | - | $888.00M | $866.00M | $899.00M | - | $855.00M | $856.00M | $908.00M | - |
| R&D | $117.00M | - | $111.00M | $112.00M | $113.00M | - | $127.00M | $113.00M | $128.00M | - |
| SG&A | $476.00M | - | $417.00M | $454.00M | $410.00M | - | $395.00M | $380.00M | $396.00M | - |
| Total Operating Expenses | $1.45B | - | $1.38B | $1.37B | $1.30B | - | $1.25B | $1.21B | $1.27B | - |
| D&A | $67.00M | - | - | - | $72.00M | - | - | - | $62.00M | - |
| Operating Income | $353.00M | - | $360.00M | $300.00M | $376.00M | - | $333.00M | $363.00M | $384.00M | - |
| Interest Expense | $25.00M | - | $28.00M | $29.00M | $28.00M | - | $22.00M | $20.00M | $22.00M | - |
| Income Tax | $59.00M | - | $30.00M | $45.00M | $49.00M | - | $61.00M | $66.00M | $55.00M | - |
| Net Income | $305.00M | - | $336.00M | $215.00M | $318.00M | - | $282.00M | $308.00M | $348.00M | - |
| EPS - Basic | $1.08 | - | $1.18 | $0.75 | $1.12 | - | $0.97 | $1.05 | $1.19 | - |
| EPS - Diluted | $1.07 | - | $1.18 | $0.75 | $1.11 | - | $0.97 | $1.05 | $1.18 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.76B | $1.79B | $1.53B | $1.49B | $1.47B | $1.33B | $1.78B | $1.67B | $1.75B | $1.59B |
| Accounts Receivable | $1.52B | $1.49B | $1.38B | $1.37B | $1.33B | $1.32B | $1.23B | $1.25B | $1.29B | $1.29B |
| Inventory | $1.06B | $1.02B | $1.01B | $991.00M | $997.00M | $972.00M | $978.00M | $1.00B | $1.03B | $1.03B |
| Accounts Payable | $602.00M | $570.00M | $530.00M | $517.00M | $547.00M | $540.00M | $497.00M | $461.00M | $488.00M | $418.00M |
| Current Assets | $4.62B | $4.59B | $4.25B | $4.21B | $4.11B | $3.96B | $4.26B | $4.20B | $4.34B | $4.19B |
| Total Assets | $12.81B | $12.73B | $12.23B | $12.16B | $11.91B | $11.85B | $11.00B | $10.86B | $10.95B | $10.76B |
| Current Liabilities | $2.23B | $2.35B | $1.89B | $2.01B | $1.87B | $1.90B | $2.39B | $1.96B | $1.62B | $1.60B |
| Long-term Debt | $3.05B | $3.05B | $3.35B | $3.35B | $3.35B | $3.35B | $2.14B | $2.14B | $2.56B | $2.73B |
| Total Liabilities | $5.91B | $5.99B | $5.86B | $6.02B | $5.89B | $5.95B | $5.09B | $4.64B | $4.76B | $4.92B |
| Stockholders' Equity | $6.91B | $6.74B | $6.37B | $6.14B | $6.03B | $5.90B | $5.90B | $6.21B | $6.19B | $5.84B |
| Retained Earnings | $1.48B | $1.39B | $1.10B | $912.00M | $916.00M | $750.00M | $773.00M | $1.09B | $1.06B | $782.00M |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $268.00M | - | - | - | $431.00M | - | - | - | $485.00M | - |
| Investing Cash Flow | ($93.00M) | - | - | - | ($94.00M) | - | - | - | ($95.00M) | - |
| Financing Cash Flow | ($222.00M) | - | - | - | ($180.00M) | - | - | - | ($240.00M) | - |
| CapEx | $93.00M | - | - | - | $97.00M | - | - | - | $90.00M | - |
| Free Cash Flow | $175.00M | - | - | - | $334.00M | - | - | - | $395.00M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 52.6% | - | 51.1% | 51.9% | 53.5% | - | 54.2% | 54.4% | 54.8% | - |
| Operating margin | 19.6% | - | 20.7% | 18.0% | 22.4% | - | 21.1% | 23.1% | 23.2% | - |
| EBITDA margin | 23.4% | - | - | - | 26.7% | - | - | - | 26.9% | - |
| Net margin | 17.0% | - | 19.3% | 12.9% | 18.9% | - | 17.9% | 19.6% | 21.0% | - |
| Free cash flow margin | 9.7% | - | - | - | 19.9% | - | - | - | 23.8% | - |
| FCF / Net income | 0.57 | - | - | - | 1.05 | - | - | - | 1.14 | - |
| R&D / Revenue | 6.5% | - | 6.4% | 6.7% | 6.7% | - | 8.0% | 7.2% | 7.7% | - |
| SG&A / Revenue | 26.5% | - | 24.0% | 27.2% | 24.4% | - | 25.0% | 24.2% | 23.9% | - |
| Effective tax rate | 16.2% | - | 8.2% | 17.3% | 13.4% | - | 17.8% | 17.6% | 13.6% | - |
| Return on assets | 2.4% | - | 2.7% | 1.8% | 2.7% | - | 2.6% | 2.8% | 3.2% | - |
| Return on equity | 4.4% | - | 5.3% | 3.5% | 5.3% | - | 4.8% | 5.0% | 5.6% | - |
| Return on invested capital | 3.0% | - | 3.4% | 2.6% | 3.5% | - | 3.4% | 3.6% | 3.8% | - |
| Liquidity | ||||||||||
| Current ratio | 2.07 | 1.96 | 2.25 | 2.09 | 2.20 | 2.09 | 1.78 | 2.15 | 2.68 | 2.61 |
| Quick ratio | 1.59 | 1.52 | 1.71 | 1.60 | 1.66 | 1.58 | 1.37 | 1.64 | 2.04 | 1.97 |
| Cash ratio | 0.79 | 0.76 | 0.81 | 0.74 | 0.78 | 0.70 | 0.74 | 0.85 | 1.08 | 0.99 |
| Leverage | ||||||||||
| Debt / Equity | 0.44 | 0.45 | 0.53 | 0.55 | 0.56 | 0.57 | 0.36 | 0.34 | 0.41 | 0.47 |
| Debt / Assets | 0.24 | 0.24 | 0.27 | 0.28 | 0.28 | 0.28 | 0.19 | 0.20 | 0.23 | 0.25 |
| Debt / EBITDA | 7.26 | - | - | - | 7.47 | - | - | - | 5.73 | - |
| Interest coverage | 14.1x | - | 12.9x | 10.3x | 13.4x | - | 15.1x | 18.1x | 17.5x | - |
| Equity multiplier | 1.85 | 1.89 | 1.92 | 1.98 | 1.98 | 2.01 | 1.86 | 1.75 | 1.77 | 1.84 |
| Liabilities / Assets | 0.46 | 0.47 | 0.48 | 0.50 | 0.49 | 0.50 | 0.46 | 0.43 | 0.43 | 0.46 |
| Efficiency | ||||||||||
| Asset turnover | 0.14 | - | 0.14 | 0.14 | 0.14 | - | 0.14 | 0.14 | 0.15 | - |
| Inventory turnover | 0.80 | - | 0.84 | 0.81 | 0.78 | - | 0.74 | 0.72 | 0.73 | - |
| Days sales outstanding | 309d | - | 290d | 299d | 288d | - | 284d | 290d | 285d | - |
| Days inventory outstanding | 454d | - | 435d | 451d | 465d | - | 494d | 509d | 503d | - |
| Days payable outstanding | 258d | - | 228d | 235d | 255d | - | 251d | 235d | 237d | - |
| Cash conversion cycle | 505d | - | 498d | 515d | 498d | - | 527d | 564d | 550d | - |
| Valuation | ||||||||||
| P / E | 125.1x | - | 97.3x | 143.5x | 136.5x | - | 145.8x | 130.5x | 110.3x | - |
| P / B | 5.5x | - | 5.1x | 5.0x | 7.2x | - | 7.0x | 6.5x | 6.2x | - |
| P / S | 21.1x | - | 18.8x | 18.4x | 25.9x | - | 26.1x | 25.5x | 23.1x | - |
| EV / EBITDA | 93.6x | - | - | - | 101.3x | - | - | - | 87.6x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 7.0% | - | 10.1% | 6.0% | 1.4% | - | -5.6% | -8.4% | -5.6% | - |
| Revenue CAGR (3y) | 0.8% | - | 0.4% | 1.2% | 0.1% | - | -0.2% | 1.0% | - | - |
| Revenue CAGR (5y) | - | - | 6.6% | 6.1% | 1.7% | - | 4.4% | 4.9% | 6.5% | - |
| Gross profit growth (YoY) | 5.2% | - | 3.9% | 1.2% | -1.0% | - | 29.9% | -7.4% | -6.2% | - |
| Operating income growth (YoY) | -6.1% | - | 8.1% | -17.4% | -2.1% | - | 150.4% | -5.2% | -9.9% | - |
| Net income growth (YoY) | -4.1% | - | 19.1% | -30.2% | -8.6% | - | 154.1% | 2.0% | -1.1% | - |
| EPS growth (YoY) | -3.6% | - | 21.6% | -28.6% | -5.9% | - | 155.3% | 2.9% | -0.8% | - |
| EPS CAGR (3y) | -3.5% | - | 2.4% | -6.2% | 6.1% | - | 4.1% | 14.5% | - | - |
| EPS CAGR (5y) | - | - | 13.0% | 18.6% | 3.6% | - | 10.1% | 13.0% | -5.6% | - |
| FCF growth (YoY) | -47.6% | - | - | - | -15.4% | - | - | - | 79.5% | - |
| FCF CAGR (5y) | - | - | - | - | 11.1% | - | - | - | 17.8% | - |
| Book value growth (YoY) | 14.6% | 14.3% | 7.9% | -1.3% | -2.6% | 0.9% | 6.2% | 7.5% | 10.3% | 10.2% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-10-31.
Business segments
$6.95B totalAgilent Cross Lab$2.91B · 41.9%
Life Sciences And Diagnostics Markets$2.73B · 39.2%
Applied Markets$1.31B · 18.9%
Product / service
$13.90B totalProduct$4.94B · 35.6%
Non Instrumentationand Other$4.52B · 32.5%
Instrumentation$2.43B · 17.5%
Service Other$2.00B · 14.4%
Geographic
$9.67B totalRest Of World$3.38B · 35.0%
US$2.34B · 24.2%
Americas$1.34B · 13.8%
CN$1.22B · 12.7%
Europe$786.00M · 8.1%
Asia Pacific$603.00M · 6.2%
Peer comparison
Same SIC group: Laboratory Analytical Instruments
Comparing AGILENT TECHNOLOGIES against the 5 most active filers in the same SIC group.
Dividends
$1.01/share trailing 12 months · +3.9% YoY
| Ex-date | Per share |
|---|---|
| Mar 31, 2026 | $0.2550 |
| Jan 6, 2026 | $0.2550 |
| Sep 30, 2025 | $0.2480 |
| Jul 1, 2025 | $0.2480 |
| Apr 1, 2025 | $0.2480 |
| Dec 31, 2024 | $0.2480 |
| Oct 1, 2024 | $0.2360 |
| Jul 2, 2024 | $0.2360 |
| Apr 1, 2024 | $0.2360 |
| Dec 29, 2023 | $0.2360 |
| Oct 2, 2023 | $0.2250 |
| Jun 30, 2023 | $0.2250 |
| Apr 3, 2023 | $0.2250 |
| Dec 30, 2022 | $0.2250 |
| Oct 3, 2022 | $0.2100 |
| Jul 1, 2022 | $0.2100 |
| Apr 4, 2022 | $0.2100 |
| Jan 3, 2022 | $0.2100 |
| Oct 4, 2021 | $0.1940 |
| Jul 2, 2021 | $0.1940 |
| Apr 5, 2021 | $0.1940 |
| Jan 4, 2021 | $0.1940 |
| Oct 5, 2020 | $0.1800 |
| Jun 29, 2020 | $0.1800 |